Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

← Older editNewer edit →
VisualWikitext
No edit summary
Snehal.Patel (talk | contribs)
editor
270 edits
No edit summary
(180 intermediate revisions by 10 users not shown)
Line 1: Line 1:
Welcome! 


*For assignments, please see the "Author" column below.  If no name is present, volunteer to create content!
*We will be creating content for all entities with genetic findings in the current WHO Classification of Tumours books.  '''<u>If there is an entity not yet listed below that you would like to author in any WHO book, we would be happy to create a page for you now</u>'''.
*To volunteer, please '''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]''' with your page of interest.
*'''<u>NOTE: A new version of the Heme/Lymphoid book (5th edition) is in beta form on the WHO website with publication of a final form anticipated by mid-2023; we're working on a plan to align the related CCGA content to the new structure.</u>'''
__TOC__
==WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th Edition) Content==
{| class="wikitable"
{| class="wikitable"
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Disease'''!!'''Page Type'''!!'''Author'''
Line 25: Line 17:
|
|
|Fabiola Quintero-Rivera (FQR)
|Fabiola Quintero-Rivera (FQR)
|Date page was created
|
|
|
|-
|-
Line 35: Line 27:
|
|
|FQR
|FQR
|Date page was created
|
|
|
|-
|-
Line 45: Line 37:
|
|
|FQR
|FQR
|Date page was created
|
|
|
|-
|-
Line 69: Line 61:
|-
|-
|    Essential  Thrombocythaemia (ET)||Disease
|    Essential  Thrombocythaemia (ET)||Disease
|Rebecca Smith
|Rebecca Smith (trainee) + Fabiola Quintero-Rivera
|
|
|
|
|complete
|complete/pending faculty review
|
|
|FQR
|FQR
Line 79: Line 71:
|-
|-
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|Chelsea D. Kramish (trainee), Daynna J.Wolff
|(trainee), Daynna J.Wolff
|
|
|
|
|complete/pending faculty review
|pending faculty review
|
|
|FQR
|FQR
Line 90: Line 82:
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|Thomas Lee
|Thomas Lee
|
|8/17/2020
|
|9/7/2020
|complete
|complete
|
|
Line 98: Line 90:
|
|
|-
|-
|'''''Mastocytosis'''''||'''''Overview'''''||Shashi Shetty, Ph.D.
|'''''Mastocytosis'''''||'''''Overview'''''||'''Shashi Shetty, Ph.D.'''
|
|
|
|
Line 107: Line 99:
|-
|-
|    Cutaneous  Mastocytosis||Disease
|    Cutaneous  Mastocytosis||Disease
|Thuy Phung + Shuo-Shawn Liu (trainee)
|Thuy Phung/Shuo-Shawn Liu
|
|
|
|
|complete
|complete/pending adding content online as of 2/4/21
|
|
|FQR
|FQR
Line 127: Line 119:
|-
|-
|    Mast Cell Sarcoma||Disease
|    Mast Cell Sarcoma||Disease
|Thuy Phung +Jordan Lowery (trainee)
|Thuy Phung +Jordan Lowery
|
|
|
|
Line 183: Line 175:
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
|Disease
|Disease
|Lauren R. Crowson-Hindman (trainee) + Daynna J. Wolff
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|
|
|
|
Line 194: Line 186:
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
|Disease
|Disease
|Lauren R. Crowson-Hindman (trainee) + Daynna J. Wolff
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|
|
|
|
Line 233: Line 225:
|
|
|9/1/20
|9/1/20
|PENDING importing content and reference formatting
|PENDING
|
|
|FQR
|FQR
|
|
|FQR has emailed SR several times, last 4/20/22
|
|-
|-
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
Line 245: Line 237:
|
|
|FQR
|FQR
|Date page was created
|
|
|
|-
|-
Line 257: Line 249:
|
|
|-
|-
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Jack Reid (trainee)+Fabiola Quintero-Rivera
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|
|
|4/21/22
|9/1/20
|pending
|pending
|
|
Line 295: Line 287:
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|
|
|9/1/20
|Complete
|PENDING
|
|
|FQR
|FQR
Line 305: Line 297:
|
|
|9/1/20
|9/1/20
|Complete
|PENDING
|
|
|FQR
|FQR
Line 332: Line 324:
|
|
|9/1/20
|9/1/20
|Complete
|PENDING
|
|
|FQR
|FQR
Line 338: Line 330:
|
|
|-
|-
|Myelodysplastic Neoplasm with Biallelic TP53 Inactivation
| || ||
|Disease
|
|Eric McGinnis
|
|
| ||
|
|
|5/4/23
|PENDING
| ||FQR
|
|
|'''Page New in 5th Edition of Book'''. 2021 template added.
|-
|-
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
Line 368: Line 358:
|
|
|
|
|''<s>PENDING</s> Complete - awaiting clarification''
|PENDING
| ||JH / MS
| ||JH / MS
|04/26/2021 -MS (re-review)
|04/26/2021 -MS (re-review)
|Review completed, awaiting some clarification from JH - 07/04/2022
|
|-
|-
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
Line 478: Line 468:
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
Corboy (Monash Health)
|
|
|
|
Line 487: Line 476:
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|
Line 495: Line 484:
|Add WHO reference
|Add WHO reference
|-
|-
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Corboy (Monash Health)
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
|
|
|
|
Line 713: Line 702:
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|Disease
|Disease
|Kay Weng Choy + Greg Corboy (Monash Health)
|Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|
Line 756: Line 745:
|
|
|
|
| ||Holli Drendel (HD)
| ||Yassmine Akkari (YA)
|
|
|
|YA (prior AE)
|-
|-
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
Line 764: Line 753:
|
|
|
|
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain (trainee) + Yassmine Akkari
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain + Yassmine Akkari
|
|
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
Line 781: Line 770:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
Line 789: Line 778:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
Line 797: Line 786:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease||Ashwini Yenamandra +
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease||Ashwini Yenamandra +
Line 808: Line 797:
|Complete
|Complete
|
|
|HD
|YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
Line 816: Line 805:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
Line 824: Line 813:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
Line 833: Line 822:
|Complete
|Complete
|
|
|HD
|YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||Holli Drendel
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||Holli Drendel
|
|
|
|
|Complete
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
Line 849: Line 838:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
Line 860: Line 849:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|YA (prior AE); NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
Line 871: Line 860:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|YA (prior AE); NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
Line 882: Line 871:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|YA (prior AE); NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
Line 893: Line 882:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|YA (prior AE); NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
Line 904: Line 893:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|YA (prior AE); NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
Line 915: Line 904:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|YA (prior AE); NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
Line 923: Line 912:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
Line 931: Line 920:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE); 2021 template added
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
Line 939: Line 928:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE); 2021 template added
|-
|-
| || ||
| || ||
Line 955: Line 944:
|
|
|
|
| ||Shivani Golem (SG)
| ||Snehal Patel (SP)
|
|
|
|SP (prior AE)
|-
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Jaime Nagy, PhD/
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
 
|
Renee Eigsti, MD
|
|
|
|
|
|PENDING
|SP
|
|
|SG
|
|
|SP (prior AE); NOTE TO BAILEY: author updating page on staging server with conversion to new template (small amount of content on older template with 4th edition content - need to convert to new template and update to 5th edition content). Then transfer to production server when ready.
|-
|-
|       Monoclonal B-cell  Lymphocytosis||Disease||Tsigab Bahta Hagos (trainee) / Shashirekha Shetty
|       Monoclonal B-cell  Lymphocytosis||Disease||
|12/19/2022
|
|1/19/2023
|
|PENDING
|
|
|SP
|
|
|SG
|
|
|SP (prior AE), 2021 template added
|-
|-
|B-cell Prolymphocytic Leukemia||Disease||
|B-cell Prolymphocytic Leukemia||Disease||
Line 984: Line 971:
|
|
|
|
|SG
|SP
|
|
|
|SP (prior AE); 2021 template added; No longer an entity
|-
|-
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
Line 993: Line 980:
|Complete
|Complete
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|Hairy Cell Leukemia||Disease||Snehal Patel
|Hairy Cell Leukemia||Disease||Snehal Patel
Line 1,002: Line 989:
|Complete
|Complete
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
Line 1,011: Line 998:
|Complete
|Complete
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
Line 1,020: Line 1,007:
|Complete
|Complete
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
Line 1,029: Line 1,016:
|Complete
|Complete
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|Lymphoplasmacytic Lymphoma||Disease||Kapitolina Semenova (trainee)+Fabiola Quintero-Rivera
|Lymphoplasmacytic Lymphoma||Disease||
|
|
|
|
|Complete
|
|
|SG
|
|4/12/2023 by FQR
|SP
|SP (prior AE); 2021 template added
|
|
|-
|-
|   Waldenstrom  Macroglobulinemia||Disease||Kapitolina Semenova (trainee)+Fabiola Quintero-Rivera
|   Waldenstrom  Macroglobulinemia||Disease||
|
|
|
|
|
|SP
|
|
|Complete
|
|
|SG
|4/12/2023 by FQR
|SP (prior AE); 2021 template added
|-
|-
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
Line 1,055: Line 1,042:
|
|
|
|
| ||SG
| ||SP
|
|
|
|SP (prior AE)
|-
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
Line 1,063: Line 1,050:
|
|
|
|
| ||SG
| ||SP
|
|
|
|SP (prior AE)
|-
|-
|    Mu Heavy Chain  Disease||Disease||
|    Mu Heavy Chain  Disease||Disease||
Line 1,071: Line 1,058:
|
|
|
|
| ||SG
| ||SP
|
|
|
|SP (prior AE)
|-
|-
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
Line 1,079: Line 1,066:
|
|
|Complete
|Complete
|5/26/2021||SG
|5/26/2021||SP
|
|
|
|SP (prior AE)
|-
|-
|    Alpha Heavy Chain  Disease||Disease||
|    Alpha Heavy Chain  Disease||Disease||
Line 1,087: Line 1,074:
|
|
|
|
| ||SG
| ||SP
|
|
|
|SP (prior AE)
|-
|-
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
Line 1,096: Line 1,083:
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
Line 1,105: Line 1,092:
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
Line 1,114: Line 1,101:
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
Line 1,123: Line 1,110:
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|    Plasmacytoma||Disease||Zhenya Tang
|    Plasmacytoma||Disease||Zhenya Tang
Line 1,132: Line 1,119:
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||Chen Yang, MD, PhD
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|
|
|
|
|Complete
|09/10/2022||SG
|
|
|SP (prior AE)
| ||SP
|
|
|-
|-
|           Primary  Amyloidosis||Disease||Heather E. Williams, PhD
|           Primary  Amyloidosis||Disease||
|
|
|
|
|?PENDING
| ||SG
|
|
|SP (prior AE)
| ||SP
|-
|           Light Chain and Heavy Chain Deposition Disease||Disease||Chen Yang, MD, PhD
|
|
|
|
|Complete
|-
|10/15/2022||SG
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
|
|
|SP (prior AE)
|-
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||Sohini Anand
|8/31/2021
|9/15/2021
|PENDING
| ||SG
|
|
|SP (prior AE)
|-
|         POEMS Syndrome||Disease||Sohini Anand, MBBS, and Tharanga Niroshini Senaratne, PhD
|
|
| ||SP
|
|
|?PENDING
| ||SG
|
|
|SP (prior AE)
|-
|-
|         TEMPI Syndrome||Disease||Sohini Anand, MBBS
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|
|
|
|?PENDING
| ||SG
|
|
|SP (prior AE)
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Whayoung Lee (trainee)/Fabiola Quintero-Rivera
|
|
| ||SP
|
|
|Complete
|
|
|SG
|4/12/23 by FQR
|SP (prior AE); 2021 template added
|-
|-
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
|         POEMS Syndrome||Disease||
|
|
|
|
|Complete
|5/28/2021||SG
|
|
|SP (prior AE)
| ||SP
|-
|
|    Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|-
|         TEMPI Syndrome||Disease||
|
|
|
| ||SP
|
|
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera
|3/9/21
|
|PENDING
|
|SP
|
|
|-
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
|
|
|Complete
|5/28/2021||SP
|
|
|-
|    Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|
|
|Complete
|Complete
|11/11/2020
|11/11/2020
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|Follicular Lymphoma||Disease||Ruthann Pfau
|Follicular Lymphoma||Disease||Ruthann Pfau
Line 1,215: Line 1,202:
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|    Testicular Follicular Lymphoma|| ||to be deleted
|    Testicular Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
|
|
|TO BE DELETED - NOT IN 5th EDITION
|-
|    In Situ Follicular Neoplasia||Disease||Rachel Burnside
|7/28/2023
|
|
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE); 2021 template added
|-
|-
|    Duodenal-Type Follicular Lymphoma||Disease||Rachel Burnside
|    Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau
|7/28/2023
|
|
|
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE); 2021 template added
|-
|-
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
Line 1,251: Line 1,238:
|Complete
|Complete
|8/16/2020
|8/16/2020
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
Line 1,259: Line 1,246:
|9/30/20
|9/30/20
|Complete
|Complete
|5/26/2021||SG
|5/26/2021||SP
|
|
|
|SP (prior AE)
|-
|-
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|
|
|
|
|Complete
|PENDING
|09/10/2022
| ||SP
|SG
|
|
|
|SP (prior AE)
|-
|-
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
Line 1,277: Line 1,263:
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Tsigab Hagos (trainee)/Shashirekha.Shetty
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||
|12/19/2022
|
|1/19/2022
|
|Pending
|
|
|SP
|
|
|SG
|
|
|SP (prior AE)
|-
|-
|    In Situ Mantle Cell  Neoplasia||Disease||Rina Kansal, MD
|    In Situ Mantle Cell  Neoplasia||Disease||
|6/12/22
|
|
|
|
|SP
|
|
|Complete
|7/26/2022
|SG
|
|
|SP (prior AE); 2021 template added
|-
|-
| || ||
| || ||
Line 1,314: Line 1,300:
|Greg Corboy (GC)
|Greg Corboy (GC)
|
|
|Requested to update 14022022
|
|-
|-
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
Line 1,324: Line 1,310:
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||Laveniya Satgunaseelan
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|26/10/2021
|
|26/1/2022
|
|Complete
|
|03/28/22||GC
| ||GC
|03/28/22
|
|2021 template added
|
|-
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
Line 1,388: Line 1,374:
|
|
|-
|-
|Intravascular Large B-cell Lymphoma||Disease||Kate Berry, Greg Corboy
|Intravascular Large B-cell Lymphoma||Disease||
|25/01/2022
|
|25/4/2022
|
|Complete
|
|9/1/22||GC
| ||GC
|9/1/22
|
|Emailed 28/3/2022 for progress update
|
|-
|-
|ALK-Positive Large B-cell Lymphoma||Disease||Nakasaki Manando (fellow), Fabiola Quintero-Rivera
|ALK-Positive Large B-cell Lymphoma||Disease||
|
|
|
|
|
|PENDING
| ||GC
| ||GC
|
|
|Nakasaki Manando removed March 2022 due to no progress/contact 1y. Added Nakasaki Manando back n 8/29/22 based on newer email communication (Jennelle's note).  2021 template added. FQR emailed Manando on 4/12/23
|
|-
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
Line 1,409: Line 1,395:
|Complete
|Complete
| ||GC
| ||GC
|28/03/2022
|
|
|
|-
|-
Line 1,428: Line 1,414:
|
|
|-
|-
|   Multicentric Castleman  Disease||Disease||Sudha Arumugam
|   Multicentric Castleman  Disease||Disease||
|10/26/2021
|
|1/26/2022
|
|Complete
|
|24/01/2022||GC
| ||GC
|24/01/2022
|
|2021 template added
|-
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Xiao Zhou, MD, PhD, Siparadigm
|10/26/2021
|1/26/2022
|PENDING
| ||GC
|
|
|Emailed 28/3/2022 for progress update
|-
|-
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||Xiao Zhou, MD, PhD, Siparadigm
|   HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|10/26/2021
|
|1/26/2022
|
|PENDING
|
| ||GC
| ||GC
|
|
|Emailed 28/3/2022 for progress update
|-
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|3/11/21
|06/28/2021
|Complete
|28/06/2021||GC
|28/06/2021
|
|
|-
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease||Lauren Shealy (trainee), Daynna Wolff
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||
|10/13/21
|01/13/2022
|Complete
|27/01/2022
|GC
|27/01/2021
|2021 template added
|-
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
|
Line 1,477: Line 1,438:
|
|
|-
|-
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||Kate Berry, Greg Corboy
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|30/05/21
|3/11/21
|30/08/21
|
|Complete
|PENDING
|24/02/2022||GC
| ||GC
|24/02/2022
|
|
|-
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Aiko Otsubo, Holli Drendel
|7/30/21
|10/30/21
|Complete
|15/11/2021
|GC
|16/11/2021
|
|
|-
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|
|
|
|
Line 1,502: Line 1,454:
|
|
|-
|-
| || ||
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|
|
|
|
|
| ||GC
|
|
| ||Sumi Kitahara (SK)
|
|
|SP (prior AE)
|-
|-
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|PENDING
| ||SK
|
|
|SP (prior AE)
| ||GC
|
|
|-
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|PENDING
| ||SK
|
|SP (prior AE)
|-
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
| ||GC
|
|
|PENDING
| ||SK
|
|
|SP (prior AE)
|-
|-
|Aggressive NK-cell Leukemia||Disease||Shanelle De Lancy, MD, Shashirekha Shetty, PhD
| || ||
|
|
|
|
|?PENDING
| ||SK
|
|
|SP (prior AE)
| ||
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|
|
|
|
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|
|
| ||SK
|
|
|SP (prior AE)
|-
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|
|
| ||Snehal Patel (SP)
|
|
|Complete
|11/21/2021||SK
|
|
|SP (prior AE)
|-
|-
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|
|
|
|
|PENDING
| ||SP
|
|
| ||SK
|
|
|SP (prior AE)
|-
|-
|    Hydroa Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|
|
|
|
|PENDING
| ||SP
|
|
| ||SK
|
|
|SP (prior AE)
|-
|-
|    Severe Mosquito Bite  Allergy||Disease||
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
|
|
|PENDING
| ||SP
|
|
| ||SK
|
|
|SP (prior AE)
|-
|-
|Adult T-cell Leukemia/Lymphoma||Disease||Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG
|Aggressive NK-cell Leukemia||Disease||
|
|
|
|
|?PENDING
| ||SK
|
|
|SP (prior AE)
| ||SP
|
|
|-
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|
|
|
|
|
| ||SP
|
|
| ||SK
|
|
|SP (prior AE)
|-
|-
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|
|
|
|
|Complete
|PENDING
|9/26/2022
| ||SP
|SK
|
|
|
|SP (prior AE)
|-
|-
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|
|
|
|
| ||SP
|
|
|Complete
|1/21/2021
|SK
|
|
|SP (prior AE)
|-
|-
|     Monomorphic Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|    Hydroa Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|PENDING
| ||SP
|
|
|SK
|
|
|SP (prior AE)
|-
|-
|     Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|    Severe Mosquito Bite Allergy||Disease||
|
|
|
|
|Complete
|9/26/2022
|SK
|
|
|SP (prior AE)
| ||SP
|-
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|-
|Adult T-cell Leukemia/Lymphoma||Disease||
|
|
|SK
|
|
|SP (prior AE)
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
| ||SP
|
|
|Complete
|1/21/2021
|SK
|
|
|SP (prior AE)
|-
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|
|
|
|
|
| ||SP
|
|
| ||SK
|
|
|SP (prior AE)
|-
|-
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|PENDING
| ||SK
|
|
|SP (prior AE)
|SP
|
|
|-
|-
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee), Tingting Barrett (trainee)
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|Complete
|1/21/2021
|SP
|
|
|PENDING
| ||SK
|
|
|SP (prior AE)
|-
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||Peining Li, PhD
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|PENDING
| ||SK
|
|
|SP (prior AE)
|SP
|
|
|-
|-
|    Lymphomatoid Papulosis||Disease||Peining Li, PhD
|     Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|PENDING
| ||SK
|
|
|SP (prior AE)
|SP
|
|
|-
|-
|    Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease||Theresa Spivey, MD, Shashirekha Shetty, PhD
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|PENDING
| ||SK
|
|
|SP (prior AE)
|SP
|
|
|-
|-
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||Peining Li, PhD
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
|
|
|PENDING
|Complete
| ||SK
|1/21/2021
|SP
|
|
|
|SP (prior AE)
|-
|-
|     Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease||Peining Li, PhD
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|
|
|
|
|PENDING
| ||SK
|
|SP (prior AE)
|-
|     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||Peining Li, PhD
|
|
| ||SP
|
|
|PENDING
| ||SK
|
|
|SP (prior AE)
|-
|-
|     Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease||Peining Li, PhD
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|
|
|
|
|PENDING
|PENDING
| ||SK
| ||SP
|
|
|
|SP (prior AE)
|-
|-
|     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||Peining Li, PhD
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
|
|
|
|
|PENDING
|PENDING
| ||SK
| ||SP
|
|
|
|SP (prior AE)
|-
|-
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Bo Hong
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||SK
| ||SP
|
|
|
|SP (prior AE); 2021 template added
|-
|-
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|    Lymphomatoid Papulosis||Disease||
|
|
|
|
|
| ||SP
|
|
| ||SK
|
|
|SP (prior AE)
|-
|-
|     Angioimmunoblastic T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|    Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease||
|
|
|
|
|
|PENDING
| ||SP
|
|
|SK
|
|
|SP (prior AE)
|-
|-
|    Follicular T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
|
|
|
|
|
|PENDING
| ||SP
|
|
|SK
|
|
|SP (prior AE)
|-
|-
|     Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|     Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease||
|
|
|
|PENDING
| ||SK
|
|
|SP (prior AE)
|-
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara / Miguel Gonzalez (trainee)
|
|
| ||SP
|
|
|Completed
|09/23/2022
|SK
|
|
|SP (prior AE)
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara  / Miguel Gonzalez (trainee)
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
|
|
|
|
|Completed
|09/23/2022
|SK
|
|
|SP (prior AE)
| ||SP
|
|
|-
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
|
|
|
|
|
|PENDING
| ||SP
|
|
|SK
|
|
|SP (prior AE)
|-
|-
| || ||
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|
| ||
| ||SP
|
|
|
|
|-
|-
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
|
| ||Greg Corboy (GC)
| ||SP
|
|
|
|
|-
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||Thomas Harrington (resident) + Daynna Wolff
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|06/22/2022
|09/22/2022
|PENDING
| ||GC
|
|
|2021 template added, Daynna organising
|-
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|
| ||SP
| ||GC
|
|
|
|
|-
|-
|    Nodular Sclerosis Classic Hodgkin Lymphoma||Disease||Xiaolin (Lynn) Hu
|     Angioimmunoblastic T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|
|
|Completed
|PENDING
|03/21/22||GC
|03/21/22
|Edits sent 14022022
|-
|    Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|
|
|SP
|
|
|PENDING
| ||GC
|
|
|2021 template added
|-
|-
|    Mixed Cellularity Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|
|
|PENDING
|PENDING
| ||GC
|
|
|2021 template added
|SP
|
|
|-
|-
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|
|
|
|
|PENDING
|PENDING
| ||GC
| ||SP
|
|
|
|2021 template added
|-
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
| ||GC
|SP
|
|
|
|
|-
|-
|Lymphomas Associated with HIV Infection||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|11/2/21
|02/02/22
|Completed
|03/21/22
|GC
|03/21/22
|2021 template added
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
|PENDING
|
|
| ||GC
|SP
|
|
|
|
|-
|-
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
| ||GC
|SP
|
|
|
|
|-
|-
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Ania Shestakova (trainee) + Fabiola Quintero-Rivera
| || ||
|
|
|
|
|completed
|
|april 2022
| ||
|GC
|
|26/4/2022
|
|
|-
|-
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||GC
| ||Greg Corboy (GC)
|
|
|
|
|-
|-
|          Monomorphic  B-cell PTLD||Disease||
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|
|
|
|
Line 1,939: Line 1,825:
|
|
|-
|-
|          Monomorphic  T/NK-cell PTLD||Disease||
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|
|
|
|
Line 1,947: Line 1,833:
|
|
|-
|-
|    Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
Line 1,955: Line 1,841:
|
|
|-
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders||Disease||
|    Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease||
|
|
|
|
Line 1,963: Line 1,849:
|
|
|-
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
Line 1,971: Line 1,857:
|
|
|-
|-
|Histiocytic Sarcoma||Disease||Marie-France Gagnon, MD, Mayo Clinic (LGG fellow trainee), Xinjie Xu, PhD FACMG, Mayo Clinic
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||
|
|
|Complete
|10/01/2021
|GC
|10/01/2021
|Xinjie Xu
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|
|
|
|
Line 1,988: Line 1,865:
|
|
|-
|-
|   Langerhans Cell  Histiocytosis||Disease||Malaika Perchard, Greg Corboy
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|02/01/2022
|05/01/2022
|Complete
|04/28/2022||GC
|5/19/2022
|
|-
|   Langerhans Cell  Sarcoma||Disease||Malaika Perchard, Greg Corboy
|02/01/2022
|05/01/2022
|Complete
|04/28/2022||GC
|5/19/2022
|
|-
|Indeterminate Dendritic Cell Tumour||Disease||
|
|
|
|
Line 2,012: Line 1,873:
|
|
|-
|-
|Interdigitating Dendritic Cell Sarcoma||Disease||
|Lymphomas Associated with HIV Infection||Disease||
|
|
|
|
Line 2,020: Line 1,881:
|
|
|-
|-
|Follicular Dendritic Cell Sarcoma||Disease||
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
Line 2,028: Line 1,889:
|
|
|-
|-
|    Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|    Non-Destructive Post-Transplant Lymphoproliferative Disorders||Disease||
|
|
|
|
Line 2,036: Line 1,897:
|
|
|-
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
 
Fabiola Quintero-Rivera
|
|
|
|
|PENDING
|
|
| ||GC
|GC
|
|
|
|
|-
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|
|
|
|
Line 2,052: Line 1,916:
|
|
|-
|-
|Erdheim-Chester Disease||Disease||Prashant Deshpande
|          Monomorphic  B-cell PTLD||Disease||
|02/02/2022
|
|05/02/2022
|
|PENDING
|
| ||GC
| ||GC
|
|
|emailed 28/3/2022 to get update
|
|-
|-
| || ||
|          Monomorphic  T/NK-cell PTLD||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|Histiocytic Sarcoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|}<br />
==WHO Classification of Soft Tissue and Bone Tumours (5th Edition) Content==
{| class="wikitable"
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
|   Langerhans Cell Histiocytosis||Disease||
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|NTRK-Rearranged Spindle Cell Neoplasm||Disease||James Solomon, MD, PhD
|2/20/2022
|
|
|PENDING
|
|
|Alanna Church
| ||GC
|
|
|
|
|-
|-
|}<br />
|   Langerhans Cell  Sarcoma||Disease||
 
==WHO Classification of Tumours of the Central Nervous System (5th Edition) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|Astrocystoma, IDH-Mutant
|Disease
|Meenakshi Mehrotra
|6/25/2023
|
|PENDING
|
|
|Laveniya Satgunaseelan (LS)
|
|
|2021 template added
|-
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor)
|6/7/2022
|
|
|COMPLETE
| ||GC
|
|
|LS
|
|
|2021 template added
|-
|-
|Glioblastoma, IDH-Wildtype||Disease||Madina Sukhanova
|Indeterminate Dendritic Cell Tumour||Disease||
|
|
|
|
|PENDING
|
|
|LS
| ||GC
|
|
|
|Moved from "Glioblasoma, IDH-wildtype" to new page; 2021 template added
|-
|-
|Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease||Scott Smith
|Interdigitating Dendritic Cell Sarcoma||Disease||
|6/27/2023
|
|
|PENDING
|
|
|LS
|
|
|2021 template added (page created 6/27/23)
| ||GC
|-
|Angiocentric Glioma||Disease||
|
|
|
|
|-
|Follicular Dendritic Cell Sarcoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease||
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
|
|-
|Diffuse Low-Grade Glioma,  MAPK Pathway-Altered||Disease||
|
|
| ||GC
|
|
|
|
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Diffuse Midline Glioma, H3  K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version)
|Erdheim-Chester Disease||Disease||
|
|
|
|
|PENDING
|
|
|LS
| ||GC
|
|
|
|2021 template added
|-
|-
|Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu
| || ||
|2/21/2022
|
|
|COMPLETE
|
|
|LS
|
|
|2021 template added
| ||
|-
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova
|10/28/2022
|
|
|COMPLETE
|
|
|LS
|
|2021 template added
|-
|-
|Infant-Type Hemispheric Glioma||Disease||
| || ||
|
|
|
|
|
|
|
| ||
|
|
|
|
|2021 template added
|-
|-
|Pilocytic Astrocytoma||Disease||Jeremy Pulvers
| || ||
|9/13/2022<br />
|
|
|PENDING
|
|
|LS
|
|
|2021 template added
| ||
|-
|High-Grade Astrocytoma with Piloid Features||Disease||
|
|
|
|
|-
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Pleomorphic Xanthoastrocytoma||Disease||
| || ||
|
|
|
|
|
|
| ||
|
|
|LS
|
|
|2021 template added
|-
|-
|Subependymal Giant Cell Astrocytoma||Disease||
| || ||
|
|
|
|
|
| ||
|
|
|
|
|-
| || ||
|
|
|
|
|
|
|-
| ||
|Chordoid Glioma||Disease||
|
|
|
|
|-
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Astroblastoma, MN1-Altered||Disease||
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|-
| || ||
|
|
|
|
|-
|Ganglioglioma||Disease||Leila Moayed-Aloei
|6/30/2022
|
|
|COMPLETE
| ||
|
|
|LS
|
|
|2021 template added
|-
|-
|Gangliocytoma||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Dysembryoplastic Neuroepithelial Tumour||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Papillary Glioneuronal Tumour||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Rosette-Forming Glioneuronal Tumour||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Myxoid Glioneuronal Tumour||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Diffuse Lptomeningeal Glioneuronal Tumour||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Multinodular and Vacuolating Neuronal Tumour||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|}
|Central Neurocytoma||Disease||
|
|
|
|
|
|
|
|-
|Extraventricular Neurocytoma||Disease||
|
|
|
|
|
|
|
|-
|Cerebellar Liponeurocytoma||Disease||
|
|
|
|
|
|
|
|-
|Supratentorial Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease||
|
|
|
|
|
|
|
|-
|Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease||
|
|
|
|
|
|
|
|-
|Posterior Fossa Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Posterior Fossa Group A (PFA) Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Posterior Fossa Group B (PFB) Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Spinal Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Spinal Ependymoma, MYCN-Amplified||Disease||
|
|
|
|
|
|
|
|-
|Myxopapillary Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Subependymoma||Disease||
|
|
|
|
|
|
|
|-
|Choroid Plexus Papilloma||Disease||
|
|
|
|
|
|
|
|-
|Atypical Choroid Plexus Papilloma||Disease||
|
|
|
|
|
|
|
|-
|Choroid Plexus Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|9/20/21
|
|COMPLETE
|
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
|9/22/2022
|2021 template added
|-
|Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease||
|
|
|
|
|
|
|
|-
|Medulloblastoma, SHH-Activated and TP53-Mutant||Disease||
|
|
|
|
|
|
|
|-
|Medulloblastoma, Non-WNT/Non-SHH||Disease||
|
|
|
|
|
|
|
|-
|Medulloblastoma, Histologically Defined||Disease||
|
|
|
|
|
|
|
|-
|Atypical Teratoid/Rhabdoid Tumour||Disease||
|
|
|
|
|
|
|
|-
|Cribriform Neuroepithelial Tumour||Disease||
|
|
|
|
|
|
|
|-
|Embryonal Tumour with Multilayered Rosettes||Disease||
|
|
|
|
|
|
|
|-
|CNS Neuroblastoma, FOXR2-Activated||Disease||
|
|
|
|
|
|
|
|-
|CNS Tumour with BCOR Internal Tandem Duplication||Disease||
|
|
|
|
|
|
|
|-
|CNS Embryonal Tumour NEC/NOS||Disease||
|
|
|
|
|
|
|
|-
|Pineocytoma||Disease||
|
|
|
|
|
|
|
|-
|Pineal Parenchymal Tumour of Intermediate Differentiation||Disease||
|
|
|
|
|
|
|
|-
|Pineoblastoma||Disease||
|
|
|
|
|
|
|
|-
|Papillary Tumour of the Pineal Region||Disease||
|
|
|
|
|
|
|
|-
|Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease||
|
|
|
|
|
|
|
|-
|Schwannoma||Disease||
|
|
|
|
|
|
|
|-
|Neurofibroma||Disease||
|
|
|
|
|
|
|
|-
|Perineurioma||Disease||
|
|
|
|
|
|
|
|-
|Hybrid Nerve Sheath Tumours||Disease||
|
|
|
|
|
|
|
|-
|Malignant Melanotic Nerve Sheath Tumour||Disease||
|
|
|
|
|
|
|
|-
|Malignant Peripheral Nerve Sheath Tumour||Disease||
|
|
|
|
|
|
|
|-
|Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease||
|
|
|
|
|
|
|
|-
|Meningioma||Disease||
|
|
|
|
|
|
|
|-
|Solitary Fibrous Tumour||Disease||
|
|
|
|
|
|
|
|-
|Haemangiomas and Vascular Malformations||Disease||
|
|
|
|
|
|
|
|-
|Haemangioblastoma||Disease||
|
|
|
|
|
|
|
|-
|Rhabdomyosarcoma||Disease||
|
|
|
|
|
|
|
|-
|Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease||
|
|
|
|
|
|
|
|-
|CIC-Rearranged Sarcoma||Disease||
|
|
|
|
|
|
|
|-
|Primary Intracranial Sarcoma, DICER1-Mutant||Disease||
|
|
|
|
|
|
|
|-
|Ewing Sarcoma||Disease||
|
|
|
|
|
|
|
|-
|Mesenchymal Chondrosarcoma||Disease||
|
|
|
|
|
|
|
|-
|Chondrosarcoma||Disease||
|
|
|
|
|
|
|
|-
|Chordoma||Disease||
|
|
|
|
|
|
|
|-
|Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease||
|
|
|
|
|
|
|
|-
|Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease||
|
|
|
|
|
|
|
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
|
|
|
|
|
|-
|Immunodeficiency-Associated CNS Lymphomas||Disease||
|
|
|
|
|
|
|
|-
|Lymphomatoid Granulomatosis||Disease||
|
|
|
|
|
|
|
|-
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|MALT Lymphoma of the Dura||Disease||
|
|
|
|
|
|
|
|-
|Other Low-Grade B-cell Lymphomas of the CNS||Disease||
|
|
|
|
|
|
|
|-
|Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease||Jennie Thurston
|7/2/2023
|
|PENDING
|
|MS
|
|2021 template added
|-
|T-cell and NK/T-cell Lymphomas||Disease||
|
|
|
|
|
|
|
|-
|Erdheim-Chester Disease||Disease||
|
|
|
|
|
|
|
|-
|Rosai-Dorfman Disease||Disease||
|
|
|
|
|
|
|
|-
|Juvenile Xanthogranuloma||Disease||
|
|
|
|
|
|
|
|-
|Langerhans Cell Histiocytosis||Disease||
|
|
|
|
|
|
|
|-
|Histiocytic Sarcoma||Disease||
|
|
|
|
|
|
|
|-
|Germ Cell Tumours of the CNS||Disease||
|
|
|
|
|
|
|
|-
|Adamantinomatous Craniopharyngioma||Disease||
|
|
|
|
|
|
|
|-
|Papillary Craniopharyngioma||Disease||
|
|
|
|
|
|
|
|-
|Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease||
|
|
|
|
|
|
|
|-
|Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease||
|
|
|
|
|
|
|
|-
|Pituitary Blastoma||Disease||
|
|
|
|
|
|
|
|-
|Metastases to the Brain and Spinal Cord Parenchyma||Disease||
|
|
|
|
|
|
|
|-
|Metastases to the Meninges||Disease||
|
|
|
|
|
|
|
|-
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
|
|
|
|
|
|
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Neurofibromatosis Type 2||Disease||
|
|
|
|
|
|
|
|-
|Schwannomatosis||Disease||
|
|
|
|
|
|
|
|-
|Von Hippel-Lindau Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Tuberous Sclerosis||Disease||
|
|
|
|
|
|
|
|-
|Li-Fraumeni Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Cowden Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Constitutional Mismatch Repair Deficiency Syndrome||Disease||Jennie Thurston
|7/2/2023
|
|PENDING
|
|LS
|
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Familial Adenomatous Polyposis 1||Disease||
|
|
|
|
|
|
|
|-
|Naevoid Basal Cell Carcinoma Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Rhabdoid Tumour Predisposition Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Carney Complex||Disease||
|
|
|
|
|
|
|
|-
|DICER1 Syndrome||Disease||Jennie Thurston
|7/2/2023
|
|PENDING
|
|LS
|
|NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Familial Paraganglioma Syndromes||Disease||
|
|
|
|
|
|
|
|-
|Melanoma-Astrocytoma Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Familial Retinoblastoma||Disease||
|
|
|
|
|
|
|
|-
|BAP1 Tumour Predisposition Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Fanconi Anaemia||Disease||
|
|
|
|
|
|
|
|-
|ELP1-Medulloblastoma Syndrome||Disease||
|
|
|
|
|
|
|
|-
|}<br />
==WHO Classification of Tumours of the Breast (5th Edition) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|- |Usual ductal hyperplasia||Disease||
|Usual Ductal Hyperplasia
|Disease
|
|
|
|
|
|-
|Columnar Cell Lesions, Including Flat Epithelial Atypia||Disease||
|
|
|
|
|
|
|
|-
|Atypical Ductal Hyperplasia||Disease||
|
|
|
|
|
|
|
|-
|Sclerosing Adenosis||Disease||
|
|
|
|
|
|
|
|-
|Apocrine Adenosis and Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Microglandular Adenosis||Disease||
|
|
|
|
|
|
|
|-
|Radial Scar/Complex Sclerosing Lesion||Disease||
|
|
|
|
|
|
|
|-
|Tubular Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Lactating Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Ductal Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Pleomorphic Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Adenomyoepithelioma||Disease||
|
|
|
|
|
|
|
|-
|Malignant Adenomyoepithelioma||Disease||
|
|
|
|
|
|
|
|-
|Intraductal Papilloma||Disease||
|
|
|
|
|
|
|
|-
|Papillary Ductal Carcinoma In Situ||Disease||
|
|
|
|
|
|
|
|-
|Encapsulated Papillary Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Solid Papillary Carcinoma (In Situ and Invasive)||Disease||
|
|
|
|
|
|
|
|-
|Invasive Papillary Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Atypical Lobular Hyperplasia||Disease||
|
|
|
|
|
|
|
|-
|Lobular Carcinoma In Situ||Disease||
|
|
|
|
|
|
|
|-
|Ductal Carcinoma In Situ||Disease||
|
|
|
|
|
|
|
|-
|Invasive Breast Carcinoma of No Special Type||Disease||
|
|
|
|
|
|
|
|-
|Microinvasive Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Invasive lobular Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Tubular Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Cribriform Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Mucinous Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Mucinous Cystadenocarcinoma||Disease||
|
|
|
|
|
|
|
|-
|Invasive Micropapillary Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Carcinoma with Apocrine Differentiation||Disease||
|
|
|
|
|
|
|
|-
|Metaplastic Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Acinic Cell Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Adenoid Cystic Carcinoma||Disease||Katherine Geiersbach
|10/12/02022
|
|PENDING
|
|Hui Chen
|
|2021 template added
|-
|Secretory Carcinoma||Disease||Hui Chen
|10/12/2022
|
|PENDING
|
|Katherine Geiersbach
|
|2021 template added
|-
|Mucoepidermoid Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Polymorphous Adenocarcinoma||Disease||
|
|
|
|
|
|
|
|-
|Tall Cell Carcinoma with Reversed Polarity||Disease||
|
|
|
|
|
|
|
|-
|Neuroendocrine Tumour||Disease||
|
|
|
|
|
|
|
|-
|Neuroendocrine Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Hamartoma||Disease||
|
|
|
|
|
|
|
|-
|Fibroadenoma||Disease||
|
|
|
|
|
|
|
|-
|Phyllodes Tumour||Disease||
|
|
|
|
|
|
|
|-
|Syringomatous Tumour||Disease||
|
|
|
|
|
|
|
|-
|Nipple Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Paget disease of the Breast||Disease||
|
|
|
|
|
|
|
|-
|Haemangioma||Disease||
|
|
|
|
|
|
|
|-
|Angiomatosis||Disease||
|
|
|
|
|
|
|
|-
|Atypical Vascular Lesions||Disease||
|
|
|
|
|
|
|
|-
|Postradiation Angiosarcoma of the Breast||Disease||
|
|
|
|
|
|
|
|-
|Primary Angiosarcoma of the Breast||Disease||
|
|
|
|
|
|
|
|-
|Nodular Fasciitis||Disease||
|
|
|
|
|
|
|
|-
|Myofibroblastoma||Disease||
|
|
|
|
|
|
|
|-
|Desmoid Fibromatosis||Disease||
|
|
|
|
|
|
|
|-
|Inflammatory Myofibroblastic Tumour||Disease||
|
|
|
|
|
|
|
|-
|Schwannoma||Disease||
|
|
|
|
|
|
|
|-
|Neurofibroma||Disease||
|
|
|
|
|
|
|
|-
|Granular Cell Tumour||Disease||
|
|
|
|
|
|
|
|-
|Leiomyoma||Disease||
|
|
|
|
|
|
|
|-
|Leiomyosarcoma||Disease||
|
|
|
|
|
|
|
|-
|Lipoma||Disease||
|
|
|
|
|
|
|
|-
|Angiolipoma||Disease||
|
|
|
|
|
|
|
|-
|Liposarcoma||Disease||
|
|
|
|
|
|
|
|-
|Pseudoangiomatous Stromal Hyperplasia||Disease||
|
|
|
|
|
|
|
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||
|
|
|
|
|
|
|
|-
|Follicular Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Diffuse Large B-cell Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Burkitt Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Gynaecomastia||Disease||
|
|
|
|
|
|
|
|-
|Carcinoma In Situ||Disease||
|
|
|
|
|
|
|
|-
|Invasive Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Metastases to the Breast||Disease||
|
|
|
|
|
|
|
|-
|BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Cowden Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Ataxia-Telangiectasia||Disease||
|
|
|
|
|
|
|
|-
|Li-Fraumeni Syndrome, TP53-Associated||Disease||
|
|
|
|
|
|
|
|-
|Li-Fraumeni Syndrome, CHEK2-Associated||Disease||
|
|
|
|
|
|
|
|-
|CDH1-Associated Breast Cancer||Disease||
|
|
|
|
|
|
|
|-
|PALB2-Associated Cancers||Disease||
|
|
|
|
|
|
|
|-
|Peutz-Jeghers Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
|
|
|
|
|
|
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Polygenic Component of Breast Cancer Susceptibility
|Disease
|
|
|
|
|
|
|
|
|-
|}<br />
==Genetic Tumour Syndromes (5th Edition) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|Constitutional Mismatch Repair Deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)||Disease||Jennie Thurston
|7/2/2023
|
|
|
|LS
|
|Named based on GTS5 book
|-
|DICER1-Related Tumour Predisposition Syndrome (DICER1)
|Disease
|Jennie Thurston
|7/2/2023
|
|
|
|LS
|
|Named based on GTS5 book
|-
|Neurofibromatosis Type 1 (NF1)
|Disease
|Ngoni Faya (trainee) + Madina Sukhanova
|7/12/2023
|
|
|
|Madina Sukhanova (Madina S)
|
|Named based on GTS5 book
|-
|}<br />
 
==Gene-Specific Pages (IN PROCESS OF AUTOMATING - HOLD ON VOLUNTEERING)==
{| class="wikitable sortable"
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Gene'''
!'''Author'''
!'''Author'''
Retrieved from "https://content.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"